Cargando…
Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources
INTRODUCTION: In addition to significant morbidity and mortality, the coronavirus disease (COVID-19) has strained health care systems globally. This study investigated the cost-effectiveness of remdesivir + standard of care (SOC) for hospitalized COVID-19 patients in the USA. METHODS: This cost-effe...
Autores principales: | Barnieh, Lianne, Beckerman, Rachel, Jeyakumar, Sushanth, Hsiao, Alice, Jarrett, James, Gottlieb, Robert L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206585/ https://www.ncbi.nlm.nih.gov/pubmed/37222933 http://dx.doi.org/10.1007/s40121-023-00816-y |
Ejemplares similares
-
Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis
por: Beckerman, Rachel, et al.
Publicado: (2022) -
IN3 Economic VALUE and Health System IMPACT of Remdesivir in Treating Hospitalized COVID-19 Patients in the United States
por: Sun, F., et al.
Publicado: (2021) -
Association of Remdesivir Treatment With Mortality Among Hospitalized Adults With COVID-19 in the United States
por: Chokkalingam, Anand P., et al.
Publicado: (2022) -
A Critical Appraisal of Matching-Adjusted Indirect Comparisons in Spinal Muscular Atrophy
por: Jiang, Tammy, et al.
Publicado: (2023) -
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
por: Murton, Molly, et al.
Publicado: (2022)